Pregled bibliografske jedinice broj: 1242423
The impact of hypoglycemia and EPA and DHA supplementation on brain-derived neurotrophic factor level in pregnant women with type 1 diabetes: a prospective cohort study
The impact of hypoglycemia and EPA and DHA supplementation on brain-derived neurotrophic factor level in pregnant women with type 1 diabetes: a prospective cohort study // Psychiatria Danubina, 33 (2021), Suppl 10; 43-51 (domaća recenzija, članak, znanstveni)
CROSBI ID: 1242423 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The impact of hypoglycemia and EPA and DHA
supplementation on brain-derived neurotrophic
factor
level in pregnant women with type 1 diabetes: a
prospective cohort study
Autori
Ivanišević, Marina ; Horvatiček, Marina ; Vučić Lovrenčić, Marijana ; Vučković Rebrina, Sandra ; Marčinko, Darko ; Đelmiš, Josip
Izvornik
Psychiatria Danubina (0353-5053) 33
(2021), Suppl 10;
43-51
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
brain-derived neurotrophic factor ; diabetes mellitus type 1 ; EPA ; DHA ; hypoglycemia-pregnancy
Sažetak
Background: In addition to its neuroprotective effect, Brain-derived neurotrophic factor (BDNF) also plays a role in glucose and lipid metabolism. This study aims: a) to find changes in the BDNF concentration during pregnancy in type 1 diabetes. b) to prove the effect of DHA and EPA supplementation on changes in BDNF concentrations c) to investigate the impact of hypoglycemia on BDNF concentration. Subjects and methods: The data from this study were from the PRE-HYPO cohort study. Twenty-one of them were on a standard diabetic diet enriched with EPA and DHA (EPA 120 mg/day and DHA 616 mg/day ; Exposed group), and nineteen pregnant diabetic women were on the standard diabetic diet without EPA and DHA supplementation (Non-exposed group). In the first trimester of pregnancy, fiftHHQ SUHJQDQW ZRPHQ GHYHORSHG K\SRJO\FHPLD HSLVRGHV .9 mmol/L ; HYPO+ group), and twenty-five pregnant women did not have hypoglycemia episodes (HYPO- group). Results: BDNF concentration significantly decreased during pregnancy from the first to the third trimester, in Non-exposed from 25.1 (22.0-30.2) to 22.1 (16.3-28.2), P<0.05, in the Exposed group from 22.1 (19.8-25.9) to 18.1 (14.8- 18.9), P<0.01. Pregnant patients with hypoglycemia episodes (HYPO+ subgroup) had significantly higher BDNF in the third trimester of pregnancy [22.5 (20.6- 28.4)] when compared with patients who did not develop hypoglycemia [16.3 (14.3-18.8), P<0.001]. In the third trimester of pregnancy, BDNF and n-6 PUFAs were associated with hypoglycemia (OR 1.818 95 % CI 1.079-3.003, P=0.025 ; OR 1.103 95 % CI 1.001-1.217, P=0.048). Total F.A.s were inversely associated with hypoglycemia (OR 0.969 95% CI 0.939- 0.998, P=0.048). Conclusion: Pregnant women with hypoglycemia (HYPO+ group) had higher concentrations of BDNF in the first and third trimesters of pregnancy compared to those without hypoglycemia. An increase in body weight during pregnancy leads to a decrease in BDNF concentration.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinička bolnica "Merkur",
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Marina Horvatiček
(autor)
Sandra Vučković-Rebrina
(autor)
Marina Ivanišević
(autor)
Darko Marčinko
(autor)
Josip Đelmiš
(autor)
Marijana Vučić Lovrenčić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE